Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : HG-CT-1
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Hemogenyx Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
Made Scientific and Hemogenyx Announce Technology Transfer and Manufacturing Partnership
Details : The partnership aims to advance HG-CT-1, Hemogenyx's Chimeric Antigen Receptor T-cell (CAR-T) therapy and lead clinical program for the treatment of relapsed/refractory acute myeloid leukemia.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
September 08, 2025
Lead Product(s) : HG-CT-1
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Hemogenyx Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : SENT-001
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Sentinel BioTherapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Made Scientific and Sentinel Announce Partnership to Advance ePP Encapsulated Cell Therapy
Details : Made Scientific is partnering with Sentinel BioTherapeutics to manufacture SENT-001, an allogeneic encapsulated cell therapy delivering IL-2 for solid tumor immunotherapy.
Product Name : SENT-001
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
July 15, 2025
Lead Product(s) : SENT-001
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Sentinel BioTherapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : TVGN-489
Therapeutic Area : Infections and Infectious Diseases
Study Phase : IND Enabling
Sponsor : Tevogen Bio
Deal Size : Undisclosed
Deal Type : Partnership
Details : Experts from both entities will collaborate at BioCentriq’s state-of-the art GMP facilities to produce Tevogen’s proprietary COVID-19 targeted T cells.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
March 15, 2021
Lead Product(s) : TVGN-489
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : IND Enabling
Sponsor : Tevogen Bio
Deal Size : Undisclosed
Deal Type : Partnership